CN101090722B - 镇痛剂 - Google Patents

镇痛剂 Download PDF

Info

Publication number
CN101090722B
CN101090722B CN200580045038XA CN200580045038A CN101090722B CN 101090722 B CN101090722 B CN 101090722B CN 200580045038X A CN200580045038X A CN 200580045038XA CN 200580045038 A CN200580045038 A CN 200580045038A CN 101090722 B CN101090722 B CN 101090722B
Authority
CN
China
Prior art keywords
allyl
cpm
carbon atoms
pain
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200580045038XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101090722A (zh
Inventor
泉本直树
川村邦昭
驹形俊和
桥本忠俊
长袋洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of CN101090722A publication Critical patent/CN101090722A/zh
Application granted granted Critical
Publication of CN101090722B publication Critical patent/CN101090722B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN200580045038XA 2004-11-04 2005-11-04 镇痛剂 Expired - Fee Related CN101090722B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP320583/2004 2004-11-04
JP2004320583 2004-11-04
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (2)

Publication Number Publication Date
CN101090722A CN101090722A (zh) 2007-12-19
CN101090722B true CN101090722B (zh) 2011-12-21

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580045038XA Expired - Fee Related CN101090722B (zh) 2004-11-04 2005-11-04 镇痛剂

Country Status (12)

Country Link
US (1) US8470845B2 (cg-RX-API-DMAC7.html)
EP (1) EP1820505A4 (cg-RX-API-DMAC7.html)
JP (1) JP4706636B2 (cg-RX-API-DMAC7.html)
KR (1) KR101285645B1 (cg-RX-API-DMAC7.html)
CN (1) CN101090722B (cg-RX-API-DMAC7.html)
AR (1) AR053098A1 (cg-RX-API-DMAC7.html)
CA (1) CA2586181C (cg-RX-API-DMAC7.html)
MX (1) MX2007005336A (cg-RX-API-DMAC7.html)
NO (1) NO20072832L (cg-RX-API-DMAC7.html)
PE (1) PE20060723A1 (cg-RX-API-DMAC7.html)
TW (1) TW200621785A (cg-RX-API-DMAC7.html)
WO (1) WO2006049248A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5119925B2 (ja) 2005-11-09 2013-01-16 東レ株式会社 機能性腸障害の治療または予防剤
CA2634055C (en) * 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
KR101546398B1 (ko) * 2007-05-21 2015-08-26 도레이 카부시키가이샤 결정성 미분화 입자
KR101510799B1 (ko) * 2007-05-21 2015-04-10 도레이 카부시키가이샤 의약 정제의 제조법
CN101848713B (zh) * 2007-05-21 2012-04-11 东丽株式会社 含有特定的有机酸的口服制剂以及口服制剂的溶出性和化学稳定性的改善方法
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique
HUE069820T2 (hu) 2018-03-08 2025-04-28 Victoria Link Ltd Nalfurafin alkalmazása demielinizációs betegségek kezelésére

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
JP2004522706A (ja) * 2000-10-31 2004-07-29 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (cg-RX-API-DMAC7.html) * 1964-02-03 1966-10-31
US3318886A (en) * 1965-07-21 1967-05-09 American Cyanamid Co Substituted 7-hydroxymethyl-7, 8-dihydro-6-amino-6, 14-endoethenocodides and morphide
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
JP2525552B2 (ja) * 1992-01-23 1996-08-21 東レ株式会社 モルヒナン誘導体および医薬用途
DE69424853T2 (de) 1993-07-23 2000-10-05 Toray Industries, Inc. Morphinan-derivate und ihre medizinische verwendung
ATE259232T1 (de) 1995-03-03 2004-02-15 Endo Pharmaceuticals Inc Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz
CN1374963A (zh) 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
US7718664B2 (en) 2004-03-30 2010-05-18 Toray Industries, Inc. Anti-itching agent

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004522706A (ja) * 2000-10-31 2004-07-29 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Sayre L. M. et al.，.Design and synthesis of Naltrexone-Derived affinitylabelswithnonequilibrium opioid agonist andantagonistactivities.Evidence for the existence of differentμreceptorsubtypes indifferent tissues.Journal of Medicinal Chemistry,第27卷， 第10期.1984,第27卷，(第10期),1325-1335.
Sayre L. M. et al.,.Design and synthesis of Naltrexone-Derived affinitylabelswithnonequilibrium opioid agonist andantagonistactivities.Evidence for the existence of differentμreceptorsubtypes indifferent tissues.Journal of Medicinal Chemistry,第27卷, 第10期.1984,第27卷,(第10期),1325-1335. *

Also Published As

Publication number Publication date
US20070299100A1 (en) 2007-12-27
TWI356826B (cg-RX-API-DMAC7.html) 2012-01-21
JP4706636B2 (ja) 2011-06-22
WO2006049248A1 (ja) 2006-05-11
US8470845B2 (en) 2013-06-25
CA2586181C (en) 2012-11-27
MX2007005336A (es) 2007-06-25
EP1820505A1 (en) 2007-08-22
EP1820505A4 (en) 2010-01-20
JPWO2006049248A1 (ja) 2008-08-07
CN101090722A (zh) 2007-12-19
KR20070085436A (ko) 2007-08-27
HK1115808A1 (en) 2008-12-12
TW200621785A (en) 2006-07-01
CA2586181A1 (en) 2006-05-11
PE20060723A1 (es) 2006-08-29
NO20072832L (no) 2007-08-01
KR101285645B1 (ko) 2013-07-12
AR053098A1 (es) 2007-04-25

Similar Documents

Publication Publication Date Title
US6174891B1 (en) Antipruritic agent
JP2525552B2 (ja) モルヒナン誘導体および医薬用途
JP3843456B2 (ja) モルヒナン誘導体および医薬用途
AU2013207811B2 (en) Anesthetic compounds and related methods of use
CN105246897B (zh) 阿片样缩酮化合物和其用途
TW200427690A (en) Opioid and opioid-like compounds and uses thereof
WO2019109937A1 (zh) Kor激动剂与mor激动剂联合在制备治疗疼痛的药物中的用途
CN101090722B (zh) 镇痛剂
CN100586434C (zh) 止痒剂
US6440987B1 (en) Antipruritic
CA2628971C (en) Therapeutic or prophylactic agent for functional bowel disorder
KR20080081057A (ko) 진해제
WO2020159565A1 (en) Methods of treating post-surgical pain with a thiazoline anti-hyperalgesic agent
WO2001074819A1 (en) Analgesics containing morphinan n-oxide derivatives as the active ingredient
HK1115808B (en) Analgesic
CN1107333A (zh) 那布扶林镇痛剂的长效前体药物及其制备方法
WO2020159588A1 (en) Methods of treating diabetic neuropathy with a thiazoline anti-hyperalgesic agent
JP7535569B2 (ja) オピオイドヘキサジエノエート及び選択的に置換されたヘキサジエノエートによってオピオイド受容体の結合を改善する組成物並びに方法
JP3531170B6 (ja) 止痒剤
JPWO2001014382A1 (ja) モルヒナン４級アンモニウム塩誘導体を有効成分とする鎮痛薬
JPWO1998023290A1 (ja) 止痒剤
HK1098679A (en) Anti-itching agent

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1115808

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1115808

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20111221

Termination date: 20191104